15 Best Long Term Low Volatility Stocks to Invest In

Page 8 of 14

7. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 93

AbbVie Inc. (NYSE:ABBV) is one of the best long term low volatility stocks to invest in. On January 27, Citi cut the price target on AbbVie Inc. (NYSE:ABBV) to $230 from $235 while maintaining a Neutral rating on the shares. The firm told investors that it adjusted price targets in the biopharma group as part of a Q4 preview, adding that “beatable” estimates and reduced policy risk are expected to create a favorable setup for the group in 2026.

However, Berenberg Bank lifted the price target on AbbVie Inc. (NYSE:ABBV) to $275 from $270 on January 20, reiterating a Buy rating. It updated its forecasts for the company’s Skyrizi and Rinvoq, and cited an “exceptional” growth outlook as one of the primary reasons behind the optimistic rating.

In a separate development, AbbVie Inc. (NYSE:ABBV) announced on January 16 topline results from its Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab in comparison to the investigator’s choice of chemoimmunotherapy in adult patients with relapsed/refractory diffuse large B-cell lymphoma. Epcoritamab is a T-cell-engaging bispecific antibody administered subcutaneously.

The study exhibited an improvement in progression-free survival, with improvements also observed in complete response rates, duration of response, and time to next treatment among patients treated with epcoritamab. AbbVie Inc. (NYSE:ABBV) further reported that the study did not demonstrate a statistically significant improvement in overall survival.

AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions.

Page 8 of 14